Safe use of landiolol hydrochloride in a patient with marked pseudocholinesterase deficiency.
Junji
J
Shiotsuka
Masamitsu
M
Sanui
Alan
A
Lefor
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000369:Aged, 80 and over; D000768:Anesthesia, General / Q000379:methods*; D002091:Butyrylcholinesterase / Q000172:deficiency* / Q000187:drug effects; D006801:Humans; D008297:Male; D009025:Morpholines / Q000627:therapeutic use*; D016896:Treatment Outcome; D014508:Urea / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017287:Ventriculoperitoneal Shunt
D000319:Adrenergic beta-Antagonists; D009025:Morpholines; C077049:landiolol; D014508:Urea; D002091:Butyrylcholinesterase